Select Countries

00
Select All
Clear All
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Rep
Chad
Comoros
Congo
Côte d’Ivoire
Djibouti
DRC
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Namibia
Niger
Nigeria
Rwanda
SADR
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe

Select Indicators

Clear All
00
Reproductive, Maternal, Neonatal and Child Health
Adolescent Fertility Rate
Births Attended by Skilled Personnel
Contraceptive Prevalence
Infant Mortality Rate
DPT3 Immunization Coverage in Children
Maternal Mortality Ratio
Neonatal Mortality Rate
Pregnant Women with 4 ANC Visits
Stunting Under 5 yrs
Under-5 Mortality Rate
Unmet Need for Family Planning
Women Who Received Post-partum Care
HIV and AIDS
Adults Tested for HIV and Know Status
HIV Knowledge (Men aged 15-24 yrs)
HIV Knowledge (Women aged 15-24 yrs)
HIV Patients Receiving Anti-retroviral Drugs
HIV Positive Pregnant Women who Receive Antiretrovirals
HIV and TB Treatment
HIV Prevalence (Females 15-24 yrs)
Pregnant Women Tested for HIV and Know Status
School Attendance of Orphans
Condom Use
Malaria and Tuberculosis
Malaria Incidence
Malaria Deaths
Pregnant Women who Received 3 Doses of IPT
Under 5s Treated with Anti-Malarial Drugs
Under 5s who Slept Under ITN
Under 5s with Fever in Last 2 Weeks Screened for Malaria
TB Case Detection Rate
TB Treatment Success Rate
Health Finance
General Gov Exp on Health as % of GGE
Out of Pocket Health Expenditure
Per Capita Public Funds for Health

Create Chart

 

 
 

Your Selection

Countries:
Indicators:
  • None selected
  • None selected

Indicator Title

Return

Indicator Information

Select Stats

Contact

Download
Print
What does it mean ?
Full Name:Proportion of pregnant women who received at least 3 doses of Intermittent Preventive Treatment for Malaria during their last pregnancy
Full Unit:%
Year-range of Data:2012 - 2014
Source:WHO World Malaria Report 2013, Annex 5
Link :http://www.who.int/malaria/publications/world-malaria-report-2015/en/
Date Source Published:9th December 2015
Date Source Accessed:13th May 2016

The following countries had no data:
Algeria, Angola, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Rep, Chad, Côte d’Ivoire, Djibouti, Egypt, Equatorial Guinea, Eritrea , Ethiopia, Guinea-Bissau, Kenya, Lesotho, Libya, Madagascar, Mauritania, Mauritius, Mozambique, Rwanda, SADR, São Tomé and Príncipe, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Swaziland, Tunisia, Uganda, Zimbabwe

Alternative Data Sources

Pregnant Women who Received 3 Doses of IPT

What does it mean ?

This indicator shows the percentage of women who received three or more doses of sulfadoxine-pyrimethamine (anti-malarial) drugs during their pregnancy administered during an antenatal care visit. It measures the proportion receiving such a treatment, out of all women age 15-49 with a live birth in the two years preceding the survey.

Why does it matter ?

Malaria infection during pregnancy is a serious public health issue posing health risks, including increased risk of death, to an expectant mother and child. The WHO recommends that all pregnant women in areas of high and moderate malaria transmission (of the type most prevalent in Africa) receive doses of sulfadoxine-pyrimethamine at each antenatal care (ANC) visit after the first trimester of pregnancy, with a minimum of three doses received during each pregnancy.

How is it collected ?

A national survey was undertaken in each country from a representative sample of households during which any woman aged 15- 49 from these sampled households was interviewed. This particular indicator only applies to women with a live birth in the two years preceding the survey.

Find out more about the Summary Definition and the Methodology for Collection and Calculation

Share this :

Close

Summary Definition, Methodology for Collection and Calculation

Alternative Data Sources

The data for each indicator on African Health Stats (AHS) are published by the UN agency, or UN inter-agency group, which holds responsibility for global monitoring of the indicator. This varies by indicator. Please refer to ‘Data Source’. AHS uses data from these sources because such data are internationally comparable and it is the mandate of those agencies to prepare such data and monitor progress internationally. In some cases the UN agency has made adjustments to the data in order to make national data internationally comparable, for example they may adjust national estimates to account for differences in survey design, the extent of potential underreporting, and the definition of what is being measured (eg. maternal deaths). This means that at times there may be discrepancies between national and international estimates. Individual countries may prefer to instead rely on national figures for national monitoring. For uniformity, AHS uses only international estimates of the UN agencies in data visualisations.

In 2014, the following countries communicated that they use alternative figures to monitor the indicator Pregnant Women who Received 2 Doses of IPT instead of the figures that appear in AHS data visualisations. The most recent alternative figure supplied by these countries in 2014, by source are: Zimbabwe 2012 35.5 (no source).

Collection Summary

A national survey was undertaken in each country from a representative sample of households during which any woman aged 15- 49 from these sampled households was interviewed. This particular indicator only applies to women with a live birth in the two years preceding the survey.

For more information, visit: http://www.who.int/malaria/publications/world-malaria-report-2015/en/

CARMMA African Union

This site is managed by the African Union's Department of Social Affairs

Language:

English

French

Keep up to date:

Twitter

Facebook